Skip to content
Open in App
Abera Bioscience logo

Abera Bioscience

web2

Abera Bioscience is a Swedish biotechnology company developing nasal vaccines against infectiou...

Symbol ยท ABERA
Company profile

About

Abera Bioscience is a Swedish biotechnology company developing nasal vaccines against infectious diseases using a modular platform based on bacterial outer membrane vesicles. Its technology is designed to present vaccine antigens and stimulate immune responses at mucosal surfaces and throughout the body. Development programs include a pneumococcal vaccine candidate preparing for clinical evaluation and an intranasal influenza vaccine undergoing preclinical research. The company investigates manufacturing approaches based on controlled fermentation and needle free administration. Abera also collaborates with research institutions and international partners on vaccine development and platform applications for additional infectious diseases.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeSpotlightPrimary symbol: ABERA
Expert coverage

Abera Bioscience profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment